Highly active compounds against COVID-19
The present invention is the use of a small group of purine nucleotide phosphoramidate disclosed herein or a pharmaceutically acceptable salt thereof in an effective amount for the treatment or prevention of the novel 2019 coronavirus disease (COVID-19) in a host, for example a human, in need thereof..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 29. Dez. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SOMMADOSSI JEAN-PIERRE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-12-29, Last update posted on www.tib.eu: 2023-11-29, Last updated: 2023-12-08 |
|---|
| Patentnummer: |
US10874687 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA006987982 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006987982 | ||
| 003 | DE-627 | ||
| 005 | 20231208120433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA006987982 | ||
| 035 | |a (EPA)US10874687 | ||
| 035 | |a (EPA)74039606 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SOMMADOSSI JEAN-PIERRE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Highly active compounds against COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-12-29, Last update posted on www.tib.eu: 2023-11-29, Last updated: 2023-12-08 | ||
| 520 | |a The present invention is the use of a small group of purine nucleotide phosphoramidate disclosed herein or a pharmaceutically acceptable salt thereof in an effective amount for the treatment or prevention of the novel 2019 coronavirus disease (COVID-19) in a host, for example a human, in need thereof. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a A01N: Preservation of bodies of humans or animals or plants or parts thereof (preservation of food or foodstuff a23); biocides, e.g. as disinfectants, as pesticides or as herbicides (preparations for medical, dental or toilet purposes which kill or prevent the growth or proliferation of unwanted organisms a61k); pest repellants or attractants; plant growth regulators | |
| 650 | 4 | |a che | |
| 650 | 4 | |a hor | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MOUSSA ADEL |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 29. Dez. |
| 773 | 1 | 8 | |g year:2020 |g day:29 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/74039606/publication/US10874687A1?q=US10874687 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2020 |b 29 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 29 |c 12 | ||